IFNG and cancer: Moreover, clinical studies have also demonstrated that the upregulation of 5-HTT and consequent reduction of extracellular 5-HT levels were observed in IFN-α and IFN-γ therapies to treat various forms of cancer and hepatitis C, in which patients often complain of serious tiredness (26, 27).